0001214659-18-006012.txt : 20180912
0001214659-18-006012.hdr.sgml : 20180912
20180912151951
ACCESSION NUMBER: 0001214659-18-006012
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180911
FILED AS OF DATE: 20180912
DATE AS OF CHANGE: 20180912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McManigle Mark Drew
CENTRAL INDEX KEY: 0001751524
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34637
FILM NUMBER: 181066740
MAIL ADDRESS:
STREET 1: PENNZOIL PLACE 700 MILAM, SUITE 1300
CITY: HOUSTON
STATE: TX
ZIP: 77002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anthera Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001316175
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201852016
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 856-5600
MAIL ADDRESS:
STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B
CITY: HAYWARD
STATE: CA
ZIP: 94545
3
1
marketforms-42916.xml
PRIMARY DOCUMENT
X0206
3
2018-09-11
1
0001316175
Anthera Pharmaceuticals Inc
ANTH
0001751524
McManigle Mark Drew
700 MILAM, SUITE 1300
PENZOIL BUILDING, NORTH TOWER
HOUSTON
TX
77003
true
true
false
false
Chief Liquidating Officer
/s/ Drew McManigle
2018-09-11